Hepatogenous diabetes in cirrhosis: Academic sport or a neglected disease?

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 8, 2012, Pages 469-471

  Gundling, F ^a   Schepp, W ^a   Schumm Draeger, P M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; METFORMIN;

ASCITES; CANCER RISK; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; HEPATIC ENCEPHALOPATHY; HEPATOGENOUS DIABETES; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; GERMANY; GLUCOSE INTOLERANCE; HEPATIC ENCEPHALOPATHY; HUMANS; INCIDENCE; LIVER CIRRHOSIS; NEGLECTED DISEASES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84866046708     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1311641     Document Type: Letter

References (19)

1. Naunyn B. Glykosurie und Diabetes durch experimentelle Insulte und Krankheiten der Leber. In: Naunyn B. ed. Der Diabetes mellitus Vienna, Austria A. Holder: 1898; 38 49
2. García-Compeán D, Jáquez-Quintana J O, Lavalle-González F J et al. The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study. Ann Hepatol: 2012; 11 240 248
3. Shetty A, Wilson S, Kuo P et al. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation: 2000; 69 2451 2454
4. Holstein A, Hinze S, Thiessen E et al. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol: 2002; 17 677 681
5. Nishida T, Tsuji S, Tsujii M et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol: 2006; 101 70 75
6. Sigal S H, Stanca C M, Kontorinis N et al. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol: 2006; 101 1490 1496
7. Gentile S, Guarino G, Romano M et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol: 2005; 3 184 191
8. Diaz J, Monge E, Roman R et al. Diabetes as a risk factor for infections in cirrhosis. Am J Gastroenterol: 2008; 103 248
9. Moreau R, Delègue P, Pessione F et al. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int: 2004; 24 457 464
10. Ha N B, Ha N B, Ahmed A et al. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control: 2012; 23 455 462
11. Huo T I, Lui W Y, Huang Y H et al. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol: 2003; 98 2293 2298
12. Nkontchou G, Cosson E, Aout M et al. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab: 2011; 96 2601 2608
13. Donadon V, Balbi M, Mas M D et al. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int: 2010; 30 750 758
14. Lai S W, Chen P C, Liao K F et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol: 2012; 107 46 52
15. www.arbeitsministerium.bayern.de/krankenhaus/plan/2007
16. www.statistik.bayern.de
17. www.blaek.de
18. Gundling F, Seidl H, Pehl C et al. How close do gastroenterologists follow specific guidelines for enteral nutrition in liver cirrhosis. Eur J Gastroenterol Hepatol: 2009; 21 756 761
19. American Diabetes Association Diagnosis and Classification of Diabetes Mellitus. Diabetes Care: 2012; 35 01 S64 S71